Hexima puts up its defensins
Thursday, 31 July, 2008
Agbiotech company Hexima [ASX: HXL] has concluded a set of trials of its defensin-based technology in cotton crops.
The trials tested the company's genetically modified strains against two common fungal diseases, verticillium wilt and fusarium wilt.
Both crops demonstrated increased yield, and the modified plants in the fusarium trial showed increased survival rates.
A third, healthy, crop was also modified with defensin to test the effect of the technology on healthy plants. The crop showed no adverse effects.
Defensins are small peptides, analogues of which are also found in humans and other animals, which help destroy bacteria and fungi. Some are also thought to have insecticidal activity.
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
